-
1دورية أكاديمية
المؤلفون: Inholz, Katharina, Anderl, Janet L., Klawitter, Moritz, Goebel, Heike, Maurits, Elmer, Kirk, Christopher J., Fan, R. Andrea, Basler, Michael
المساهمون: Deutsche Forschungsgemeinschaft
المصدر: European Journal of Immunology ; volume 54, issue 4 ; ISSN 0014-2980 1521-4141
-
2دورية أكاديمية
المؤلفون: El‐Ayoubi, Ali, Arakelyan, Arsen, Klawitter, Moritz, Merk, Luisa, Hakobyan, Siras, Gonzalez‐Menendez, Irene, Quintanilla Fend, Leticia, Holm, Per Sonne, Mikulits, Wolfgang, Schwab, Matthias, Danielyan, Lusine, Naumann, Ulrike
المساهمون: Deutsche Krebshilfe
المصدر: Molecular Oncology ; volume 18, issue 3, page 528-546 ; ISSN 1574-7891 1878-0261
-
3دورية أكاديمية
المؤلفون: El‐Ayoubi, Ali, Arakelyan, Arsen, Klawitter, Moritz, Merk, Luisa, Hakobyan, Siras, Gonzalez‐Menendez, Irene, Quintanilla Fend, Leticia, Holm, Per Sonne, Mikulits, Wolfgang, Schwab, Matthias, Danielyan, Lusine, Naumann, Ulrike
المصدر: Molecular Oncology; Mar2024, Vol. 18 Issue 3, p528-546, 19p
-
4دورية أكاديمية
المؤلفون: Klawitter, Moritz, El-Ayoubi, Ali, Buch, Jasmin, Rüttinger, Jakob, Ehrenfeld, Maximilian, Lichtenegger, Eva, Krüger, Marcel A., Mantwill, Klaus, Koll, Florestan J., Kowarik, Markus C., Holm, Per Sonne, Naumann, Ulrike
مصطلحات موضوعية: info:eu-repo/classification/ddc, Article, glioblastoma, oncolytic virotherapy, immune checkpoint inhibition, abscopal effects, XVir-N-31
وصف الملف: application/pdf
العلاقة: https://mediatum.ub.tum.de/1690959Test; https://mediatum.ub.tum.de/doc/1690959/document.pdfTest
الإتاحة: https://doi.org/10.3390/ijms23179965Test
https://mediatum.ub.tum.de/1690959Test
https://mediatum.ub.tum.de/doc/1690959/document.pdfTest -
5دورية أكاديمية
المؤلفون: El-Ayoubi, Ali1 (AUTHOR) a_ayoubi@outlook.com, Klawitter, Moritz1 (AUTHOR) moritz.klawitter@t-online.de, Rüttinger, Jakob1 (AUTHOR) jakob.ruettinger@student.uni-tuebingen.de, Wellhäusser, Giulia1 (AUTHOR) wellhaueser.giulia@gmail.com, Holm, Per Sonne2,3,4 (AUTHOR) per-sonne.holm@i-med.ac.at, Danielyan, Lusine5,6 (AUTHOR) lusine.danielyan@med.uni-tuebingen.de, Naumann, Ulrike1,7 (AUTHOR) ulrike.naumann@uni-tuebingen.de
المصدر: Cancers. Oct2023, Vol. 15 Issue 20, p4912. 16p.
مصطلحات موضوعية: *BIOLOGICAL models, *BRAIN, *INJECTIONS, *XENOGRAFTS, *BLOOD-brain barrier, *ANIMAL experimentation, *VIRAL load, *GLIOMAS, *CANCER relapse, *ADENOVIRUSES, *TREATMENT effectiveness, *CANCER patients, *INTRANASAL administration, *SURVIVAL analysis (Biometry), *RESEARCH funding, *CELL lines, *ONCOLYTIC virotherapy, *MICE, *CELL death, *EVALUATION
-
6
المؤلفون: Klawitter, Moritz Dominik
المساهمون: Naumann, Ulrike (Prof. Dr.)
مصطلحات موضوعية: PD-L1, Onkovirotherapie, XVir-N-31, PD-1, XVir-N-31, Onkovirotherapy
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od_______707::dd3bc6f3deadcfb796dc31df3ffae69bTest
https://hdl.handle.net/10900/139181Test -
7
المؤلفون: Klawitter, Moritz, El-Ayoubi, Ali, Buch, Jasmin, Rüttinger, Jakob, Ehrenfeld, Maximilian, Lichtenegger, Eva, Krüger, Marcel A., Mantwill, Klaus, Koll, Florestan J., Kowarik, Markus C., Holm, Per Sonne, Naumann, Ulrike
مصطلحات موضوعية: Article, glioblastoma, oncolytic virotherapy, immune checkpoint inhibition, abscopal effects, XVir-N-31, ddc
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od_______518::b94eb46c71b914676ddb01bf112a4a62Test
https://mediatum.ub.tum.de/1690959Test -
8رسالة جامعية
المؤلفون: Klawitter, Moritz
المساهمون: Eberhard Karls Universität Tübingen
العلاقة: http://dx.doi.org/10.15496/publikation-80528Test; http://hdl.handle.net/10900/140473Test; http://dx.doi.org/10.15496/publikation-81820Test
الإتاحة: https://doi.org/10.15496/publikation-81820Test
https://doi.org/10.15496/publikation-80528Test
http://hdl.handle.net/10900/140473Test -
9دورية أكاديمية
المؤلفون: Basler, Michael1,2 michael.basler@uni-konstanz.de, Claus, Meike1, Klawitter, Moritz1, Goebel, Heike1, Groettrup, Marcus1,2
المصدر: Journal of Immunology. Oct2019, Vol. 203 Issue 7, p1776-1785. 10p.
مصطلحات موضوعية: *MONOCYTES, *INFLAMMATORY mediators, *SECRETION, *CELL death